NCT04236362 A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT04234607 A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) Status UNKNOWN Phase PHASE3
NCT04211896 Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT04207463 A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors Status UNKNOWN Phase PHASE2
NCT04203719 A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer Status UNKNOWN Phase PHASE2
NCT04197492 Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04157140 Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC Status UNKNOWN Phase PHASE2
NCT04147728 Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC Status UNKNOWN Phase PHASE2
NCT04136535 Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC Status RECRUITING Phase PHASE2
NCT04106024 Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial Status UNKNOWN Phase PHASE2
NCT04080154 Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04073550 Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT04073537 Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT04004975 Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib Status UNKNOWN Phase PHASE1/PHASE2
NCT03996408 Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03991975 Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma Status UNKNOWN Phase PHASE1/PHASE2
NCT03983928 Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT03975036 Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody Status UNKNOWN Phase PHASE2/PHASE3